CDKN2A and thymic carcinoma: Thymomas frequently exhibit mutations in GTF2I, while thymic carcinomas have mutations in TP53, CDKN2A/B, and, in advanced forms, mutations in genes that control chromatin modifications and epigenetic regulation processes.